121 related articles for article (PubMed ID: 37721395)
1. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours.
Simon J; Perez-Rivas LG; Zhao Y; Chasseloup F; Lasolle H; Cortet C; Descotes F; Villa C; Baussart B; Burman P; Maiter D; von Selzam V; Rotermund R; Flitsch J; Thorsteinsdottir J; Jouanneau E; Buchfelder M; Chanson P; Raverot G; Theodoropoulou M
Eur J Endocrinol; 2023 Sep; 189(3):372-378. PubMed ID: 37721395
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Pathological, and Molecular Factors of Aggressiveness in Lactotroph Tumours.
Trouillas J; Delgrange E; Wierinckx A; Vasiljevic A; Jouanneau E; Burman P; Raverot G
Neuroendocrinology; 2019; 109(1):70-76. PubMed ID: 30943495
[TBL] [Abstract][Full Text] [Related]
3. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
[TBL] [Abstract][Full Text] [Related]
4. Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia.
Faraoni EY; Abeledo Machado AI; Pérez PA; Marcial López CA; Camilletti MA; Peña-Zanoni M; Rulli SB; Gutiérrez S; Díaz-Torga G
J Endocrinol; 2020 Feb; 244(2):415-429. PubMed ID: 32395971
[TBL] [Abstract][Full Text] [Related]
5. The SF3B1
Guo J; Li C; Fang Q; Liu Y; Wang D; Chen Y; Xie W; Zhang Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):26. PubMed ID: 35039052
[TBL] [Abstract][Full Text] [Related]
6. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
[TBL] [Abstract][Full Text] [Related]
7. Differences between rat strains in the development of PRL-secreting pituitary tumors with long-term estrogen treatment: In vitro insulin-like growth factor-1-induced lactotroph proliferation and gene expression are affected in Wistar-Kyoto rats with low estrogen-susceptibility.
Mitsui T; Ishida M; Izawa M; Arita J
Endocr J; 2013; 60(11):1251-9. PubMed ID: 23985690
[TBL] [Abstract][Full Text] [Related]
8. Postoperative remission of non-invasive lactotroph pituitary tumor: A single-center experience.
Lasolle H; Teulade M; Lapras V; Vasiljevic A; Borson-Chazot F; Jouanneau E; Raverot G
Ann Endocrinol (Paris); 2022 Feb; 83(1):1-8. PubMed ID: 34871604
[TBL] [Abstract][Full Text] [Related]
9. Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With Prognosis.
Isaacson AL; Sompallae RR; Guseva NV; Bellizzi AM; Bossler AD; Ma D
Am J Clin Pathol; 2022 Aug; 158(2):177-186. PubMed ID: 35212356
[TBL] [Abstract][Full Text] [Related]
10. Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis.
Rose AM; Luo R; Radia UK; Kalirai H; Thornton S; Luthert PJ; Jayasena CN; Verity DH; Coupland SE; Rose GE
BMC Cancer; 2018 Dec; 18(1):1262. PubMed ID: 30558566
[TBL] [Abstract][Full Text] [Related]
11. Somatic SF3B1 hotspot mutation in prolactinomas.
Li C; Xie W; Rosenblum JS; Zhou J; Guo J; Miao Y; Shen Y; Wang H; Gong L; Li M; Zhao S; Cheng S; Zhu H; Jiang T; Ling S; Wang F; Zhang H; Zhang M; Qu Y; Zhang Q; Li G; Wang J; Ma J; Zhuang Z; Zhang Y
Nat Commun; 2020 May; 11(1):2506. PubMed ID: 32427851
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features.
Magri F; Villa C; Locatelli D; Scagnelli P; Lagonigro MS; Morbini P; Castellano M; Gabellieri E; Rotondi M; Solcia E; Daly AF; Chiovato L
J Endocrinol Invest; 2010 May; 33(5):325-31. PubMed ID: 19955848
[TBL] [Abstract][Full Text] [Related]
13. Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes.
Volpe VO; Al Ali N; Chan O; Padron E; Sallman DA; Kuykendall A; Sweet K; Lancet JE; Komrokji RS
Br J Haematol; 2022 Aug; 198(4):713-720. PubMed ID: 35751140
[TBL] [Abstract][Full Text] [Related]
14. Alteration of SF3B1 and SRSF2 Genes in Myelodysplastic Syndromes Patients in Upper Northern Thailand.
Yimpak P; Tantiworawit A; Rattanathammethee T; Angsuchawan S; Laowatthanapong S; Tasuya W; Bumroongkit K
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1215-1221. PubMed ID: 31030497
[TBL] [Abstract][Full Text] [Related]
15. Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients.
Sadria R; Motamed N; Saberi Anvar M; Mehrabani Yeganeh H; Poopak B
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1757. PubMed ID: 36411516
[TBL] [Abstract][Full Text] [Related]
16. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
18. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.
Samy A; Ozdemir MK; Alhajj R
Sci Rep; 2023 Feb; 13(1):2704. PubMed ID: 36792691
[TBL] [Abstract][Full Text] [Related]
19. Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1.
Ok CY; Trowell KT; Parker KG; Moser K; Weinberg OK; Rogers HJ; Reichard KK; George TI; Hsi ED; Bueso-Ramos CE; Tam W; Orazi A; Bagg A; Arber DA; Hasserjian RP; Wang SA
Mod Pathol; 2021 Jan; 34(1):20-31. PubMed ID: 32694616
[TBL] [Abstract][Full Text] [Related]
20. Oophorectomy improves pituitary activin inhibitory function preventing lactotroph hyperplasia development.
Peña-Zanoni M; Faraoni EY; Abeledo-Machado A; Perez PA; Marcial López CA; Camilletti MA; Gutierrez S; Rulli SB; Diaz-Torga G
Endocr Relat Cancer; 2022 May; 29(6):359-373. PubMed ID: 35324456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
